Nisa Leung
Managing Partner at Qiming Venture Partners\
United States
Overview
Work Experience
Managing Partner
2006 - Current
Member Board Of Directors
2021
Investor
2018
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Raised $1,054,400,640.00 from Sage Partners, Surveyor Capital, Woodline Partners, TF Capital, Lilly Asia Ventures, Casdin Capital, Eight Roads Ventures, Cormorant Asset Management, TCG Crossover and Biotechnology Value Fund.
Board Member
2014
Board Member
2016
Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.
Board Member / Investor
2019
Investor
2024
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Raised $271,339,991.00 from Qiming Venture Partners.
Board Member
2020
Investor
2022
Curie.Bio is a founder-focused seed-stage venture capital firm.
Board Member
2019
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.
Raised $222,000,000.00 from Sands Capital Ventures, Pura Vida Investments, Sherpa Healthcare Partners and Qiming Venture Partners.